top of page
Insights and News Curated for Life Science Experts by Life Science Experts....
INSIGHTS HUB
Deepfakes: A Growing Threat to Hiring in the Life Sciences Industry
As Life Sciences recruiting becomes more selective and AI has continued advancement, incorporating these technologies into recruitment...
The FTC Ban on Non-Competes – From Life Science Recruiters’ Perspective
In a landmark decision, the Federal Trade Commission (FTC) has voted 3-2 to approve the issuance of a final rule that could reshape the...
Automation in Talent Attraction: fighting candidate pre-conditioning.
How automation has corrupted candidate attraction, and what can you as a Hiring Manger or Talent Acquisition Professional do to be more...
Search
Capstan Therapeutics announces $175M Oversubscribed Series B Financing
San Diego, CA, March 20, 2024 (Capstan) -- Capstan Therapeutics, Inc. (“Capstan”), has successfully secured a $175 million...
Dr. David Battleman Appointed President & CEO of BioFuse Medical Technologies, Leading Advancements in Surgical Innovation
Melbourne, FL, March 26, 2024 (Accesswire) -- BioFuse Medical Technologies appoints David Battleman, MD, MBA, MSc, as President & CEO...
Avenzo Therapeutics announces $150M Oversubscribed Financing to Advance Emerging Oncology Pipeline
San Diego, CA, March 26, 2024 (Business Wire) -- Avenzo Therapeutics concludes an oversubscribed $150 million Series A-1 financing...
Julien Sauvagnargues Appointed CEO of Olympus Corporation of the Americas
Center Valley, PA, March 27, 2024 (PRNewswire) -- Olympus Corporation of the Americas (OCA), a global MedTech leader, has appointed...
Mirador has raised more than $400M in Financing led by ARCH Venture Partners
San Diego, CA, March 21, 2024 (Business Wire) -- Founded by Mark C. McKenna and guided by a team of seasoned executives from Prometheus...
Sionna Therapeutics Announce $182M Series C Financing
Waltham, MA, March 8, 2024 (Cystic Fibrosis News Today) -- Sionna Therapeutics has secured $182 million in financing to propel the...
Vaxart, Inc. Appoints Steven Lo as CEO
San Francisco, CA, March 06, 2024 (GlobeNewswire) -- Vaxart, Inc. (Nasdaq: VXRT) has named Steven Lo as its President and Chief...
Alumis Announces $259M Series C Financing
South San Francisco, CA, March 6, 2024 (VC News Daily) -- Alumis Inc., a pioneering clinical-stage biopharmaceutical enterprise...
ChemoMetec Appoints Martin Helbo Behrens as New CEO, Effective Immediately
Denmark, March 13, 2024 (GlobeNewswire) -- The Board of Directors of ChemoMetec appoints current COO Martin Helbo Behrens as new CEO. ...
Novartis Acquires IFM for $835M to Advance First-In-Class STING Antagonist Program Targeting the Innate Immune System
Boston, MA, March 13, 2024 (PR Newswire) -- IFM Therapeutics, a leading biopharmaceutical firm specializing in innovative therapies for...
AbbVie Announces Appointment of Robert A. Michael as CEO
North Chicago, IL, February 20, 2024 (PRNewswire) -- AbbVie (NYSE: ABBV) announced that Robert A. Michael, the current president and...
Alamar Biosciences Raises $128M in Oversubscribed Series C
Fremont, CA, February 26, 2024 (PRNewswire) -- Alamar Biosciences, a company specializing in precision proteomics for early disease...
BRIJ Medical Appoints Tim Gleeson as CEO
Marietta, GA, February 13, 2024 (PRNewswire) -- BRIJ Medical announces Tim Gleeson as CEO and Joe Andrew as Senior VP of sales. Tim...
AbbVie to Pay OSE Immunotherapeutics an Upfront Payment of $48M and Offer Potential Additional Milestone Payments of up to $665M
North Chicago, IL, and Nantes, France, February 28, 2024 (PRNewswire) -- AbbVie and OSE Immunotherapeutics announced a partnership to...
Agiliti to be taken private by THL partners with an Enterprise Value of $2.5B
Minneapolis, MN, February 28, 2024 (Reuters) -- Agiliti Inc. (NYSE:AGTI), a provider of medical technology management and service...
Procyrion successfully secures $57.7M in series E funding
Houston, February 5, 2024 (PRNewswire) -- Procyrion™, Inc., focused on enhancing patient outcomes in cardiac and renal care, has...
Catalyst Clinical Research welcomes Nik Morton as new CEO
Wilmington, NC, February 14, 2024 (PRNewswire) -- Catalyst Clinical Research appointed Nik Morton as its CEO. Stepping into the role...
Latigo Biotherapeutics launches with $135M Series A funding to advance development of non-opioid pain treatments
Thousands Oaks, CA, February 14, 2024 (PRNewswire) -- Latigo Biotherapeutics has announced that it has completed a $135 million series...
BRIJ Medical appoints Tim Gleeson as CEO
Marietta, GA, February 13, 2024 (PRNewswire) -- BRIJ Medical appointed Tim Gleeson as their new CEO. Tim brings a wealth of medical...
Gilead to buy CymaBay in $4.3B deal for liver disease drug
Foster City, CA, February 12, 2024 (Yahoo Finance) -- Gilead Sciences announces acquisition of CymaBay Therapeutics in a $4.3 billion...
bottom of page